Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

NeuroHealing Tackling Brain Injury With Dopamine Agonist

Sep. 9, 2005

By Jennifer Boggs

Alliance Shifts Astral Subsidiary To MultiCell, Retains One-Third

Sep. 9, 2005

By Jennifer Boggs

NeuroHealing Tackling Brain Injury With Dopamine Agonist

Sep. 9, 2005

By Jennifer Boggs

Alliance Shifts Astral Subsidiary To MultiCell, Retains One-Third

Sep. 9, 2005

By Jennifer Boggs

Series A Brings OncoMed $14M For Cancer Stem Cell Products

Sep. 8, 2005

By Jennifer Boggs

Series A Brings OncoMed $14M For Cancer Stem Cell Products

Sep. 8, 2005

By Jennifer Boggs

Cephalon Files For Clearance Of OraVescent Fentanyl Tablet

Sep. 7, 2005

By Jennifer Boggs

Cephalon Files For Clearance Of OraVescent Fentanyl Tablet

Sep. 7, 2005

By Jennifer Boggs

International Series A Brings Norwegian Firm Algeta EUR23M

Sep. 6, 2005

By Jennifer Boggs

International Series A Brings Norwegian Firm Algeta EUR23M

Sep. 6, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...